Tribune Therapeutics AB
Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases.
Series A ·
Amount not disclosed in a source on record.
Funding history ↓Signals
About Tribune Therapeutics AB
It was founded in 2020 with funding from HealthCap and Novo Seeds.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | undisclosed | — | fundraisingfox.com |
Timeline
- Website created
Founders and team
OK
Ole Kaasboell Founder- OKOle Kaasbøll co-foundersource: tribunetx.com
JH
Jonas Hansson Executive Chairman
Investors
Companies like Tribune Therapeutics AB
MMatchpoint Therapeutics$150M Series B+ · Oct 2026
AAdcytherixSeries A · Oct 2025
CClaris Bio$118M Series B+ · Jul 2026
OOncusp TherapeuticsSeries A · Nov 2025MMirador Therapeutics$250M Series B+ · Jan 2026
AApollo Therapeutics$226.5M Series B+ · Sep 2023
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/tribune-therapeutics-ab (get a free API key).